Nitches announced the forthcoming launch of its science-based bioceutical product line. After extensive research and collaboration with scientists, doctors, and FDA-approved manufacturing facilities, Nitches is poised to unveil a suite of revolutionary products designed to enhance human performance and well-being. Scheduled for release in October 2024, this line will introduce three bioceutical products, each developed with the highest standards of scientific rigor and innovation. The company’s proprietary formulations have been crafted in collaboration with leading experts and manufactured in FDA-registered and routinely audited facilities in the United States. Adhering to the most stringent standards, including FDA 21 CFR 111 – Current Good Manufacturing Practices, and certifications such as NSF and ISO-90001, Nitches ensures unparalleled quality and safety in every product. The upcoming product line is aimed at supporting a wide range of health and wellness needs, catering to both teenagers and adults. Nitches is currently in the final stages of discovery and formulation and is preparing to reveal detailed information about the product line, including ingredients, benefits, and usage, in the coming weeks. The official launch event will take place in October, where the company will provide a comprehensive overview of the new products and their potential to revolutionize the nutraceutical industry.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NICH: